AzTrials
AzTrials

Neurogenic Lower Urinary Tract DysfunctionNCT02443870

Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction

An observational study of Neurogenic Lower Urinary Tract Dysfunction, run by Swiss Paraplegic Research, Nottwil at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The long-term changes of bladder function in individuals with lower urinary tract dysfunction will be investigated. Patients presenting for regular urodynamic examination of bladder function will be included. Bladder diary details and urodynamic data will be collected in order to investigate bladder function. Read more about this study

Who is it for?
Ages 18 years and older
How many people
250 participants
Where
1 siteSwitzerland
Study dates
May 2015to Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: individuals with neurogenic lower urinary tract dysfunction

Who may be able to join

  • neurogenic lower urinary tract dysfunction
  • urodynamic data

Who cannot join

  • duration of neurogenic lower urinary tract dysfunction < 10 years
  • < 5 urodynamic follow-ups

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Swiss Paraplegic Centre

    Nottwil, Canton of Lucerne, CH-6207

Other trials in Switzerland

About this study

Official title: Retrospective Analysis of Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction

The long-term changes of bladder function in individuals with lower urinary tract dysfunction will be investigated. Patients presenting for regular urodynamic examination of bladder function will be included. Bladder diary details and urodynamic data will be collected in order to investigate bladder function.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. maximal detrusor storage pressure

    Measured: 12 month after previous investigation

Secondary outcomes (4)
  1. bladder capacity

    Measured: 12 month after previous investigation

  2. bladder compliance

    The relationship between a change in bladder volume and the change in detrusor pressure (ΔDV/ΔDP).

    Measured: 12 month after previous investigation

  3. maximal detrusor voiding pressure

    Measured: 12 month after previous investigation

  4. reflexive bladder volume

    Measured: 12 month after previous investigation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2015 (estimated)
  2. Study startMay 2015
  3. Primary completionJul 2023
  4. Study completionSep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02443870
Sponsor's protocol ID
2013-11
Status last verified
Sep 2023
First submitted
6 May 2015
Last updated
28 Sep 2023
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Neurogenic Lower Urinary Tract Dysfunction, run by Swiss Paraplegic Research, Nottwil at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

maximal detrusor storage pressure (time frame: 12 month after previous investigation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in